ATP13A2 has been implicated in melanoma, colon cancer, hepatocellular carcinoma, acute myeloid leukemia and non‐small‐cell lung cancer [39, 40, 41, 42, 43]. Here, ATP13A2 is linked to hepatocellular carcinoma.